ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,121.66
1.13%
Dow Jones
38,664.55
1.15%
US Dollar vs MXN
17.00055
0.17%
Brent Oil
83.145
-0.58%
Bitcoin
61,724.86
4.40%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. AMEX
  6. Elite Pharmaceuticals, (ELI)

  7. Elite Pharmaceuticals, (ELI) Noticias

ELI

Elite Pharmaceuticals (ELI)

Elite Pharmaceuticals,
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:AMEX:ELI
FechaHoraFuenteTítuloSímboloCompañía
11/05/200911:56Edgar (US Regulatory)-National Securities Exchange Report the Removal from listing and reg. of matured,redeemed or retired securities (25)AMEX:ELIElite Pharmaceuticals,
06/05/200912:20Edgar (US Regulatory)Current report filing (8-K)AMEX:ELIElite Pharmaceuticals,
21/04/200915:44Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ELIElite Pharmaceuticals,
14/04/200916:28Edgar (US Regulatory)Amended Current report filing (8-K/A)AMEX:ELIElite Pharmaceuticals,
23/03/200910:39Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)AMEX:ELIElite Pharmaceuticals,
06/03/200914:48Edgar (US Regulatory)Statement of Beneficial Ownership (SC 13D)AMEX:ELIElite Pharmaceuticals,
17/02/200915:33Edgar (US Regulatory)Quarterly Report (10-Q)AMEX:ELIElite Pharmaceuticals,
17/02/200906:37Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)AMEX:ELIElite Pharmaceuticals,
16/01/200916:23Edgar (US Regulatory)Amended Annual Report (10-K/A)AMEX:ELIElite Pharmaceuticals,
21/11/200814:45Edgar (US Regulatory)Proxy Statement (definitive) (DEF 14A)AMEX:ELIElite Pharmaceuticals,
20/11/200805:08Edgar (US Regulatory)Proxy Soliciting Materials (revised) (PRER14A)AMEX:ELIElite Pharmaceuticals,
13/11/200816:31Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (PRE 14A)AMEX:ELIElite Pharmaceuticals,
01/10/200815:25Edgar (US Regulatory)Elite Pharmaceuticals Inc /DE/ - Current report filing (8-K)AMEX:ELIElite Pharmaceuticals,
29/09/200811:14MarketwiredAnalyst Reports for Mad Catz Interactive Inc., Elite Pharmaceuticals Inc., Peace Arch Entertainment Group Inc. and Evergreen IncAMEX:ELIElite Pharmaceuticals,
12/08/200811:35Edgar (US Regulatory)Elite Pharmaceuticals Inc /DE/ - Quarterly Report (10-Q)AMEX:ELIElite Pharmaceuticals,
25/07/200813:06Edgar (US Regulatory)Elite Pharmaceuticals Inc /DE/ - Statement of Changes in Beneficial Ownership (4)AMEX:ELIElite Pharmaceuticals,
27/06/200815:42Edgar (US Regulatory)Elite Pharmaceuticals Inc /DE/ - Annual Report (10-K)AMEX:ELIElite Pharmaceuticals,
03/06/200813:36Edgar (US Regulatory)Elite Pharmaceuticals Inc /DE/ - Amended Statement of Ownership (SC 13G/A)AMEX:ELIElite Pharmaceuticals,
27/05/200811:55Edgar (US Regulatory)Elite Pharmaceuticals Inc /DE/ - Proxy Statement (definitive) (DEF 14A)AMEX:ELIElite Pharmaceuticals,
21/05/200814:22Edgar (US Regulatory)Elite Pharmaceuticals Inc /DE/ - Proxy Soliciting Materials (revised) (PRER14A)AMEX:ELIElite Pharmaceuticals,
15/05/200814:53Edgar (US Regulatory)Elite Pharmaceuticals Inc /DE/ - Proxy Statement - Notice of Shareholders Meeting (preliminary) (PRE 14A)AMEX:ELIElite Pharmaceuticals,
14/02/200808:00Business WireElite Pharmaceuticals, Inc. to Present Clinical Data at the American Academy of Pain Medicine's 24th Annual MeetingAMEX:ELIElite Pharmaceuticals,
31/01/200810:49Edgar (US Regulatory)Elite Pharmaceuticals Inc /DE/ - Prospectus filed pursuant to Rule 424(b)(3) (424B3)AMEX:ELIElite Pharmaceuticals,
28/01/200805:00Edgar (US Regulatory)Elite Pharmaceuticals Inc /DE/ - Notice of Effectiveness (EFFECT)AMEX:ELIElite Pharmaceuticals,
25/01/200805:01Edgar (US Regulatory)Elite Pharmaceuticals Inc /DE/ - Statement of Ownership (SC 13G)AMEX:ELIElite Pharmaceuticals,
02/01/200816:28Edgar (US Regulatory)Elite Pharmaceuticals Inc /DE/ - Securities Registration Statement (simplified form) (S-3/A)AMEX:ELIElite Pharmaceuticals,
13/11/200716:11Edgar (US Regulatory)Elite Pharmaceuticals Inc /DE/ (Other) (8-K)AMEX:ELIElite Pharmaceuticals,
24/10/200715:46Edgar (US Regulatory)Elite Pharmaceuticals Inc /DE/ - Current report filingAMEX:ELIElite Pharmaceuticals,
18/07/200707:40Business WireElite Announces Closing of Series C Private PlacementAMEX:ELIElite Pharmaceuticals,
28/06/200716:42Business WireElite Pharmaceuticals Provides Update on Company's Progress and Projected MilestonesAMEX:ELIElite Pharmaceuticals,
 Showing the most relevant articles for your search:AMEX:ELI

Su Consulta Reciente

NYSE
AXP
American Express
NYSE
KO
Coca Cola
USOTC
DTEGY
Deutsche Telekom (QX)
NASDAQ
AAPL
Apple
CCOM
SILVER
SILVER
NASDAQ
NVDA
NVIDIA
USOTC
BNPQY
BNP Paribas (QX)
CCOM
US30
US 30
CCOM
OILBRENT
Brent Oil
FX
USDMXN
US Dollar vs MXN
NYSE
MCD
McDonalds
NYSE
CVX
Chevron
COIN
ETHUSD
Ethereum
AMEX
XLF
Financial Select Sector
FX
EURMXN
Euro vs MXN
NASDAQ
GOOGL
Alphabet
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados